In 2020, 25% of US adults with chronic pain managed their symptoms with medication alone versus nonpharmalogic treatments such as physical, occupational, or cognitive behavioral therapies.
A study demonstrates that effective, intensive pain therapy is not simply a matter of administering the correct analgesic, according to an anesthesiologist.
The US Food and Drug Administration (FDA) has expanded the indication for Abbott Laboratories spinal cord stimulation (SCS) devices to include treatment of chronic back pain.